51 patients with depressive episode (40--recurrent depressive disorder, 11--bipolar affective disorder) were treated by the clomipramine intravenous infusions. The number of infusions varied from 5 to 21 (mostly 10-16). The median of maximal dose was 150 mg. There were significant clinical improvement measured by CGI. The therapy was well tolerated.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[intravenous clomipramine
4
clomipramine depressive
4
depressive disorders]
4
disorders] patients
4
patients depressive
4
depressive episode
4
episode 40--recurrent
4
40--recurrent depressive
4
depressive disorder
4
disorder 11--bipolar
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!